The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The Enhanced Metastatic Potential of Hepatocellular Carcinoma (HCC) Cells with Sorafenib Resistance
Authors
Keywords
-
Journal
PLoS One
Volume 8, Issue 11, Pages e78675
Publisher
Public Library of Science (PLoS)
Online
2013-11-12
DOI
10.1371/journal.pone.0078675
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Label-retaining liver cancer cells are relatively resistant to sorafenib
- (2013) Hong-Wu Xin et al. GUT
- Hepatocellular carcinoma and sorafenib: too many resistance mechanisms?
- (2013) Carmen Berasain GUT
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- Role of sorafenib in the treatment of advanced hepatocellular carcinoma: An update
- (2012) Angela Gauthier et al. HEPATOLOGY RESEARCH
- EGFR activation is a potential determinant of primary resistance of hepatocellular carcinoma cells to sorafenib
- (2012) Zakaria Ezzoukhry et al. INTERNATIONAL JOURNAL OF CANCER
- Epidermal growth factor receptor and HER-3 restrict cell response to sorafenib in hepatocellular carcinoma cells
- (2012) Marie-José Blivet-Van Eggelpoël et al. JOURNAL OF HEPATOLOGY
- Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma
- (2012) Masahito Nakano et al. ONCOLOGY
- Survival after Locoregional Treatments for Hepatocellular Carcinoma: A Cohort Study in Real-World Patients
- (2012) Simona Signoriello et al. TheScientificWorldJOURNAL
- Clinicopathological and prognostic significance of epithelial mesenchymal transition-related protein expression in intrahepatic cholangiocarcinoma
- (2012) Xing Yao et al. OncoTargets and Therapy
- Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways
- (2011) Olorunseun O. Ogunwobi et al. CLINICAL & EXPERIMENTAL METASTASIS
- Long-Term Safety and Tolerability of Sorafenib in Patients with Advanced Non–Small-Cell Lung Cancer: A Case-Based Review
- (2011) Alex A. Adjei et al. Clinical Lung Cancer
- Activation of Phosphatidylinositol 3-Kinase/Akt Signaling Pathway Mediates Acquired Resistance to Sorafenib in Hepatocellular Carcinoma Cells
- (2011) K.-F. Chen et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Sorafenib Inhibits the Hepatocyte Growth Factor-Mediated Epithelial Mesenchymal Transition in Hepatocellular Carcinoma
- (2011) T. Nagai et al. MOLECULAR CANCER THERAPEUTICS
- Dovitinib Induces Apoptosis and Overcomes Sorafenib Resistance in Hepatocellular Carcinoma through SHP-1-Mediated Inhibition of STAT3
- (2011) W.-T. Tai et al. MOLECULAR CANCER THERAPEUTICS
- Hepatocellular Carcinoma
- (2011) Hashem B. El-Serag NEW ENGLAND JOURNAL OF MEDICINE
- Long-term safety of sorafenib in advanced renal cell carcinoma: Follow-up of patients from phase III TARGET
- (2010) Thomas E. Hutson et al. EUROPEAN JOURNAL OF CANCER
- Solitary cell infiltration is a novel indicator of poor prognosis and epithelial-mesenchymal transition in pancreatic cancer
- (2010) Yohei Masugi et al. HUMAN PATHOLOGY
- Targeting cancer stem cells by inhibiting Wnt, Notch and Hedgehog pathways
- (2010) Naoko Takebe et al. Nature Reviews Clinical Oncology
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer
- (2010) A Singh et al. ONCOGENE
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Prognostic importance of epithelial-mesenchymal transition-related protein expression in gastric carcinoma
- (2009) Min A Kim et al. HISTOPATHOLOGY
- New insights of epithelial-mesenchymal transition in cancer metastasis
- (2008) Yadi Wu et al. ACTA BIOCHIMICA ET BIOPHYSICA SINICA
- Liver stem cells and hepatocellular carcinoma
- (2008) Lopa Mishra et al. HEPATOLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started